Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model

Flow diversion is a disruptive technology for the treatment of intracranial aneurysms. However, these intraluminal devices pose a risk for thromboembolic complications despite dual antiplatelet therapy. We report the thrombogenic potential of the following flow diversion devices measured experimenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Girdhar, Gaurav, Ubl, Samantha, Jahanbekam, Reza, Thinamany, Sinduja, Belu, Anna, Wainwright, John, Wolf, Michael F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350389/
https://www.ncbi.nlm.nih.gov/pubmed/30723811
http://dx.doi.org/10.1016/j.ensci.2019.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350389/
https://www.ncbi.nlm.nih.gov/pubmed/30723811
http://dx.doi.org/10.1016/j.ensci.2019.01.004

Ejemplares similares